# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-20-123055
Filing Date
2020-11-09
Accepted
2020-11-09 16:08:30
Documents
72
Period of Report
2020-09-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM 10-Q | mrkr-20200930x10q.htm iXBRL | 10-Q | 1853645
2 | EXHIBIT 10.1 | mrkr-20200930xex10d1.htm | EX-10.1 | 50839
3 | EXHIBIT 10.2 | mrkr-20200930xex10d2.htm | EX-10.2 | 42494
4 | EXHIBIT 31.1 | mrkr-20200930xex31d1.htm | EX-31.1 | 11892
5 | EXHIBIT 31.2 | mrkr-20200930xex31d2.htm | EX-31.2 | 11718
6 | EXHIBIT 32.1 | mrkr-20200930xex32d1.htm | EX-32.1 | 6592
7 | EXHIBIT 32.2 | mrkr-20200930xex32d2.htm | EX-32.2 | 6467
13 | GRAPHIC | mrkr-20200930x10q001.jpg | GRAPHIC | 8326
14 | GRAPHIC | mrkr-20200930x10q002.jpg | GRAPHIC | 20477
| Complete submission text file | 0001104659-20-123055.txt |  | 6656746

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
8 | XBRL TAXONOMY EXTENSION SCHEMA | mrkr-20200930.xsd | EX-101.SCH | 42925
9 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE | mrkr-20200930_cal.xml | EX-101.CAL | 36387
10 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE | mrkr-20200930_def.xml | EX-101.DEF | 75177
11 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | mrkr-20200930_lab.xml | EX-101.LAB | 290025
12 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | mrkr-20200930_pre.xml | EX-101.PRE | 232696
15 | EXTRACTED XBRL INSTANCE DOCUMENT | mrkr-20200930x10q_htm.xml | XML | 1330461

Mailing Address 3200 SOUTHWEST FREEWAY SUITE 2250 HOUSTON TX 77027
Business Address 3200 SOUTHWEST FREEWAY SUITE 2250 HOUSTON TX 77027 (713) 400-6400
Marker Therapeutics, Inc. (Filer) CIK: 0001094038 (see all company filings)

EIN.: 880277072 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37939 | Film No.: 201297744
SIC: 2834 Pharmaceutical Preparations